Marcus Rennick, Epidemiologist with the Marion County Public Health Department (WV), provides an overview/training on the BioSense System.
Time Overview:
(45 minutes) Syndromic Surveillance and BioSense Overview
(90 minutes) Hands-on BioSense Tutorial
(20 minutes) Introduction and hands-on to other ways to access the data than just the front end application
(20 minutes) Resources and Community Support
In February, ISDS and the BioSense Redesign Team hosted a Webinar on winter weather surveillance. Now, as the weather becomes warmer, we invite you to learn about what two midwestern states do for heat-related illness (HRI) surveillance. Fatema Mamou and Bill Storm, epidemiologists from Michigan and Ohio, will describe how they conduct HRI surveillance and what they do with the information once it's gathered. They will focus on multiple methodologies and systems, including their states' home syndromic surveillance systems as well as BioSense 2.0.
Presented February 9, 2012
Webinar Time: 12:00 PM - 1:00 PM EST
BioSense 2.0 protects the health of the American people by providing timely insight into the health of communities, regions, and the nation by offering a variety of features to improve data collection, standardization, storage, analysis, and collaboration. BioSense 2.0 is the result of a partnership between the Centers for Disease Control and Prevention (CDC) and the public health community to track the health and well-being of communities across the country. As part of the redesign effort, new fat pipe system architecture has recently been implemented to improve the features and capabilities of the system.
Objective
The objective of this presentation is to provide an overview of the technical architecture of BioSense 2.0.
The CDC's BioSense 2.0 system is designed with a user-centered approach, where the needs and requests of the users are part of its continued development. User requirements were gathered extensively to help design BioSense 2.0 and users continue to submit feedback which is used to make improvements to the system. However, in order to ensure that these needs are gathered in a formal and ongoing way, the BioSense 2.0 Governance Group, comprised primarily of state and local public health representatives, was established to advise the CDC on the development of BioSense 2.0. The Governance Group (GG) understands that to make recommendations having direct relevance and utility to the community, they must engage public health jurisdictions which use BioSense 2.0. To that end, the GG has conducted three surveys of the BioSense 2.0 community. The survey results will help inform the group's prioritized recommendations to the CDC.
Objective
In this presentation we discuss the findings and lessons learned from these surveys.